OxDX
About OxDX
OxDX has developed a one-minute pathogen detection platform that utilizes computer vision and a single reagent for simultaneous identification of multiple pathogens. This technology addresses the need for rapid, affordable diagnostics at the point of care, significantly reducing wait times for test results and improving patient triage in healthcare settings.
```xml <problem> Current point-of-care (POC) diagnostic tests for infectious diseases often take up to 30 minutes to produce results, which can delay treatment decisions and strain healthcare resources. Existing POC tests also typically require multiple pathogen-specific reagents, complicating inventory management and limiting the breadth of detectable pathogens. </problem> <solution> Pictura Bio has developed a rapid pathogen detection platform that delivers lab-quality results in approximately one minute. The platform utilizes a single universal reagent and computer vision to simultaneously identify multiple pathogens from a single sample. The system consists of three core components: PIC-ID Capture, which uses a single reagent to make pathogens detectable; the VISTA Reader, which runs the test and captures digital images via fluorescence microscopy; and PIC-ID Identify, which employs image analysis to identify and differentiate between all pathogens present. This approach enables faster and more affordable diagnostics at the point of care, improving patient triage and reducing the time to appropriate treatment. </solution> <features> - One-minute pathogen detection using computer vision and fluorescence microscopy - Single-reagent system for simplified inventory and broad pathogen coverage - VISTA Reader device for automated test execution and image capture - PIC-ID Identify module for simultaneous identification of multiple pathogens - AI-powered image analysis for accurate and rapid results - Portable design for use in diverse point-of-care settings - Cloud connectivity for instant updates and remote diagnostics </features> <target_audience> The primary target audience includes frontline healthcare professionals, emergency departments, and healthcare systems seeking rapid, actionable diagnostic information at the point of care. </target_audience> ```
What does OxDX do?
OxDX has developed a one-minute pathogen detection platform that utilizes computer vision and a single reagent for simultaneous identification of multiple pathogens. This technology addresses the need for rapid, affordable diagnostics at the point of care, significantly reducing wait times for test results and improving patient triage in healthcare settings.
Where is OxDX located?
OxDX is based in Haddington, United Kingdom.
When was OxDX founded?
OxDX was founded in 2021.
- Location
- Haddington, United Kingdom
- Founded
- 2021 0